KCPG
Kavar Capital Partners Group’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-3,746
| Closed | -$35K | – | 416 |
|
|
2019
Q2 | $35K | Buy |
+3,746
| New | +$35K | 0.01% | 264 |
|
|
2018
Q3 | – | Sell |
-3,468
| Closed | -$84K | – | 347 |
|
|
2018
Q2 | $84K | Hold |
3,468
| – | – | 0.04% | 150 |
|
|
2018
Q1 | $59K | Buy |
+3,468
| New | +$59K | 0.03% | 173 |
|
|
2017
Q3 | – | Sell |
-30,072
| Closed | -$999K | – | 113 |
|
|
2017
Q2 | $999K | Sell |
30,072
-1,256
| -4% | -$41.7K | 0.54% | 67 |
|
|
2017
Q1 | $1.01M | Buy |
31,328
+1,112
| +4% | +$35.7K | 0.56% | 67 |
|
|
2016
Q4 | $1.1M | Sell |
30,216
-13,472
| -31% | -$488K | 0.69% | 61 |
|
|
2016
Q3 | $2.01M | Buy |
43,688
+1,110
| +3% | +$51.1K | 1.3% | 28 |
|
|
2016
Q2 | $2.14M | Buy |
42,578
+3,405
| +9% | +$171K | 1.38% | 25 |
|
|
2016
Q1 | $2.1M | Buy |
39,173
+4,507
| +13% | +$241K | 1.39% | 22 |
|
|
2015
Q4 | $2.28M | Buy |
34,666
+4,657
| +16% | +$306K | 1.46% | 17 |
|
|
2015
Q3 | $1.69M | Buy |
30,009
+695
| +2% | +$39.2K | 1.2% | 30 |
|
|
2015
Q2 | $1.73M | Buy |
29,314
+4,693
| +19% | +$277K | 1.18% | 32 |
|
|
2015
Q1 | $1.53M | Buy |
24,621
+2,037
| +9% | +$127K | 1.3% | 30 |
|
|
2014
Q4 | $1.3M | Sell |
22,584
-400
| -2% | -$23K | 1.02% | 42 |
|
|
2014
Q3 | $1.24M | Sell |
22,984
-1,125
| -5% | -$60.5K | 1.06% | 34 |
|
|
2014
Q2 | $1.26M | Hold |
24,109
| – | – | 1.07% | 27 |
|
|
2014
Q1 | $1.27M | Buy |
24,109
+91
| +0.4% | +$4.81K | 1.05% | 23 |
|
|
2013
Q4 | $962K | Buy |
+24,018
| New | +$962K | 0.86% | 47 |
|